Serial No. 114-173: Bioresearch Labs and Inactivation of Dangerous Pathogens, Hearing Before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Fourteenth Congress, Second Session, September 27, 2016 [open pdf - 3MB]
This is the September 27, 2016 hearing on "Biosearch Labs and Inactivation of Dangerous Pathogens" held before U.S. House of Representatives Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce. The purpose of this hearing was expressed in Tim Murphy's opening statement: "[T]oday this subcommittee will continue our examination of bioresearch labs and handling of dangerous pathogens, including the 66 pathogens classified as Federal Select Agents. Specifically, we will focus on the inactivation of bacteria and viruses, or making dangerous organisms harmless and incapable of spreading disease while retaining characteristics for future use including crucial biodefense research. This research allows for the development of diagnostic tests to detect emerging infectious diseases as well as discovering vaccines and other medical countermeasures to protect us from epidemics." Statements, letters, and materials submitted for the record include those of the following: Timothy Person, Daniel M. Sosin, Stephan S. Monroe, Mark Davidson, Jeffrey Potts, Barbara R. Holcomb.
Serial No. 114-173
Government Publishing Office: https://www.gpo.gov